Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
McKesson
Harvard Business School
Moodys
Deloitte
Fish and Richardson
Johnson and Johnson
Chinese Patent Office
Cipla

Generated: May 26, 2018

DrugPatentWatch Database Preview

CITANEST Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Summary for CITANEST
Drug patent expirations by year for CITANEST
Synonyms for CITANEST
.alpha.-n-Propyl-amino-2-methylpropionanilide
(.+/-.)-Prilocaine
(+/-)-Prilocaine
(RS)-N-(2-Methylphenyl)-2-(propylamino)propanamide
2-(Propylamino)-N-(o-tolyl)propanamide
2-(Propylamino)-o-propionotoluidide
2-Methyl-.alpha.-propylaminopropionanilide
2-Methyl-alpha-propylaminopropionanilide
4CH-023339
721-50-6
721-50-6,1786-81-8(HCl)
86P818
A837435
AB00053665
AB00053665_13
AB00053665_14
AB00053665-12
AB2000166
ABP000640
AC-2100
AC1L1J7W
ACT04759
AK161940
AKOS015889404
alpha-n-Propylamino-2-methylpropionanilide
Ambap1786-81-8
AN-14288
ARONIS27056
AS-14851
Astra 1512
Astra 1515
BC209871
BPBio1_000173
BRD-A53952395-003-05-3
BRN 2108498
BSPBio_000157
BSPBio_002604
C07531
CCG-205085
CHEBI:8404
CHEMBL1194
Citanest (TN)
CS-1929
CTK2H7603
D-(-)-PRILOCAINE
D00553
D06LYG
DB00750
DivK1c_000846
DR000423
DTXSID7031955
EBD798
EINECS 211-957-0
FT-0603506
FT-0660568
GTPL7276
HMS3604H09
HMS3651M13
HSDB 3386
HY-B0137
I01-1860
IDI1_000846
KBio1_000846
KBio2_002129
KBio2_004697
KBio2_007265
KBio3_001824
KBioGR_001883
KBioSS_002129
KS-00000XMI
KS-000048JX
L 67
Lopac0_001005
LS-2304
MCULE-7176365958
MFCD00048681
MolPort-005-935-583
MVFGUOIZUNYYSO-UHFFFAOYSA-N
N-(2-Methylphenyl)-2-(propylamino)propanamide
N-(2-Methylphenyl)-2-(propylamino)propanamide #
N-(2-methylphenyl)-2-(propylamino)propanimidic acid
N-(2-methylphenyl)-2-propylamino-propanamide
N-(2-methylphenyl)-N(2)-propylalaninamide
N-(2-methylphenyl)-N~2~-propylalaninamide
N-(2-methylphenyl)-N2-propylalaninamide
N-(o-tolyl)-2-(propylamino)propanamide
N-[2-Methylphenyl]-2-[propylamino]propanamide
N1-(2-methylphenyl)-N2-propylalaninamide
NCGC00015860-02
NCGC00015860-03
NCGC00162312-01
NE41881
NINDS_000846
NSC 40027
NSC-40027
NSC40027
o-Methyl-.alpha.-propylaminopropionanilide
o-Methyl-2-propylaminopropionanilide
o-Methyl-alpha-propylaminopropionanilide
o-Propionotoluidide, 2-(propylamino)-
o-Propionotoluidide, 2-propylamino-
o-Propionotuluidide, 2-propylamino-
OR220089
OR332876
Prestwick0_000199
Prestwick1_000199
Prestwick2_000199
Prestwick3_000199
Prilocain
Prilocaina
Prilocaina [INN-Spanish]
prilocaine
Prilocaine (USP/INN)
Prilocaine [USAN:USP:INN:BAN]
Prilocaine [USAN]
prilocaine base
Prilocaine/
Prilocainum
Prilocainum [INN-Latin]
Prilotekal
Propanamide, N-(2-methylphenyl)-2-(propylamino)-
Propanamide, N-(2-methylphenyl)-2-(propylamino)- (9CI)
Propanamide, N-(2-methylphenyl)-2-(propylamino)-(9CI)
Propitocaine
Propitocaine (JAN)
Propitocaine HCl
Propranamide, N-(2-methylphenyl)-2-(propylamino)-
Q-100809
s1619
SBI-0050978.P003
SC-26688
SCHEMBL25467
SPBio_001398
SPBio_002078
Spectrum_001649
Spectrum2_001549
Spectrum3_001052
Spectrum4_001192
Spectrum5_001175
STL257086

US Patents and Regulatory Information for CITANEST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca CITANEST prilocaine hydrochloride INJECTABLE;INJECTION 014763-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dentsply Pharm CITANEST PLAIN DENTAL prilocaine hydrochloride INJECTABLE;INJECTION 021382-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca CITANEST FORTE epinephrine bitartrate; prilocaine hydrochloride INJECTABLE;INJECTION 014763-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca CITANEST prilocaine hydrochloride INJECTABLE;INJECTION 014763-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Johnson and Johnson
Fuji
Dow
Chinese Patent Office
UBS
US Department of Justice
Cerilliant
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.